
India-UK FTA offers clear benefits, but long-term impact depends on execution and political will
On a warm July afternoon at Chequers, Prime Ministers Keir Starmer and Narendra Modi finally signed the Comprehensive Economic and Trade Agreement (CETA), which negotiators from London and New Delhi have been pursuing since 2022. The deal is the largest the UK has sealed since Brexit and India's first with a G7 economy in over a decade, marking the end of a stop-start process that spanned four Indian budget cycles and two British prime ministers.
For London, the agreement is intended to deliver the 'Global Britain' dividend that has eluded successive Conservative governments since the United Kingdom departed from the European Union. Labour's new leadership can now point to preferential access to a market of 1.4 billion people for sectors ranging from premium spirits to cutting-edge aerospace. At the same time, India gains early access to European markets just as its export-led 'Make in India for the World' strategy accelerates. Strategically, the pact aligns neatly with the wider India–UK Roadmap 2030, which already encompasses cooperation on climate action, critical minerals, and maritime security, providing both capitals with a rules-based alternative to supply-chain dependence on China.
At the heart of CETA lie steep tariff cuts. Average Indian duties on British goods drop from around 15 per cent to just 3 per cent on 90 per cent of tariff lines, with the eye-catching reduction on Scotch whisky — from 150 per cent today to 75 per cent immediately and 40 per cent over ten years. High-end cars arriving from the UK will see levies plummet from well over 100 per cent to 10 per cent within a quota of 25,000 units, and British salmon, chocolates, and cheese will enter on near-zero tariffs. In return, the UK eliminates duties on almost every Indian export, from labour-intensive textiles and leather to gems, generic pharmaceuticals and marine produce.
While India–UK trade currently represents a relatively modest share of each country's overall external sector — accounting for approximately 2.4 per cent of the UK's total trade and about 1.8 per cent of India's combined merchandise and services trade as of 2024 — the bilateral relationship has demonstrated consistent upward momentum. Investment linkages are equally significant, reflecting a mutually reinforcing economic interdependence supported by a dynamic ecosystem of transnational firms.
Against this backdrop, the proposed trade agreement carries both symbolic and material promise. The UK Treasury anticipates an annual GDP increase of approximately £4.8 billion by 2040, alongside investment and export gains valued at £6 billion. Concurrently, India's Ministry of Commerce projects a potential expansion of up to US$34 billion in bilateral trade over five years. Though these figures may appear modest in terms of aggregate GDP — translating to less than half a percentage point of output for either country — they hold considerable significance at the sectoral and regional levels. Targeted tariff reductions and regulatory alignment are poised to deliver significant benefits for key constituencies, including Scottish distilleries, Midlands car manufacturers, Tirupur knitwear exporters, and India's rapidly growing processed food and marine sectors.
Still, the agreement leaves several concerns unaddressed. Delhi had lobbied strongly for a more expansive 'Mode 4' mobility framework to facilitate the movement of its IT professionals — seeking concessions on par with those granted to Australia. However, Britain's domestic immigration politics constrained the scope of the offer. Meanwhile, Britain's financial and legal sectors are frustrated by the absence of the preferential access they enjoy under the UK-Australia deal, just as Indian agricultural exporters continue to face rigorous sanitary and phytosanitary checks on goods like mangoes, chillies, and seafood.
Crucially, the bilateral investment treaty, intended to anchor investor-state dispute settlement provisions, remains under negotiation, leaving key protections undefined. The agreement's implementation is also not immediate — it must first pass through parliamentary scrutiny in Westminster and receive Cabinet approval in New Delhi — a process that could be delayed if domestic lobbies or legislators seek exemptions. India was also unsuccessful in securing an exemption from the UK's forthcoming Carbon Border Adjustment Mechanism, which could result in future tariffs on carbon-intensive exports.
Moving forward, several critical dimensions merit attention: Whether subnational actors such as Maharashtra or Gujarat design targeted incentive frameworks to optimise access to UK public procurement markets; how India's existing goods trade deficit with the UK shapes domestic political discourse, particularly if imports of Scotch whisky or luxury vehicles expand significantly; and whether a potential digital trade protocol can facilitate UK fintech integration with India Stack's public digital infrastructure, contingent upon India's willingness to revisit data localisation policies.
Finally, the India–UK trade pact may not constitute a transformational macroeconomic breakthrough, but it holds considerable geopolitical significance and commercial relevance across a diverse array of sectors. The substantive value of the agreement will depend less on its formalisation at Chequers and more on the efficiency of its ratification processes, the robustness of regulatory implementation, and the extent to which both governments can resist domestic protectionist pressures that risk diluting the intended liberalising thrust.
The writer is a Fellow and Lead, World Economies and Sustainability at the Centre for New Economic Diplomacy (CNED) at Observer Research Foundation (ORF)
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Economic Times
11 minutes ago
- Economic Times
Eris Lifesciences eyes ‘good' share in semaglutide generics, says COO
Mr. Krishnakumar Vaidyanathan, Executive Director & Chief Operating Officer Eris Lifesciences looks to leverage its experience in integrated diabetes portfolio to take a lead among the first wave of generic semaglutide anti-diabetic and weight-loss drugs to hit the market early next year, a top official said. The company is looking at a 'good' share of the market, Krishnakumar Vaidyanathan, executive director and chief operating officer of Eris Lifesciences, told ET in an interaction. Semaglutide is the active ingredient in Novo Nordisk's blockbuster drugs Wegovy and Ozempic. Its patent in India will expire in March 2026. 'We are gearing up to be among the first to enter the market post loss of exclusivity,' Vaidyanathan said. 'We expect the overall market for GLP-1 at the end of the first 12 months (after the loss of exclusivity) to be at least 10 million units… And we expect to get a good share of the market.' Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist. Eris Lifesciences' existing diabetes portfolio includes orals, insulin and GLP-1 in the form of liraglutide. Its network of field representatives, patient connect and service platform in this space gives the firm an advantage over others, Vaidyanathan said. 'We do this day in and day out because of insulin. That gives us the confidence that we'll be able to step this up for GLP-1 as well.'Globally, the GLP-1 market is dominated by Eli Lilly and Novo Nordisk, which are also the two biggest insulin companies in the world. 'Being successful and big in the insulin market provides a huge tailwind when it comes to selling GLPs,' Vaidyanathan said. 'We have combined service with technology and product to create a winning combination in insulin and GLP therapy entry is not any different, which also requires a lot of patient education over and above the service on using the pens,' he said. 'We have an integrated diabetes portfolio because we currently sell GLP-1 in the form of liraglutide.' Dr Reddy's Labs, Sun Pharmaceutical Industries, Cipla, Mankind Pharma, Torrent Pharmaceuticals, and Zydus Lifesciences are also among Indian drugmakers readying to launch generic semaglutide next year. Eris Lifesciences launched liraglutide, a once-a-week GLP-1 product, last September. 'We have taken very good market shares in all the other LOE (loss of exclusivity) opportunities that we have seen in diabetes,' Vaidyanathan said. 'We have taken market ranks of 1 to 5 in each one without exception – vildagliptin, sitagliptin, linagliptin, dapagliflozin and empagliflozin. That gives us the confidence that we should be getting a fair share of the market.' Vishal Manchanda, pharma analyst at brokerage Systematix Group, said its full portfolio of anti-diabetes drugs to offer to diabetologist, spanning all oral and injectable options, should give Eris Lifesciences 'a strong positioning in a market where the large pharma majors like Sun, Lupin, Dr Reddy's, Cipla, Mankind and Zydus come in with their dominant brand presence.'


Hans India
14 minutes ago
- Hans India
Vedanta continues winning street confidence: Brokerages forecast strong earnings ahead
New Delhi: Major global and Indian brokerages remain optimistic on Vedanta Ltd's performance for FY26, citing stronger LME pricing trends, cost discipline, deleveraging, and a resilient aluminium business among the key growth drivers. These firms have also taken note of the several growth projects scheduled for commissioning or completion in the next few quarters. JP Morgan noted that Vedanta's first quarter consolidated EBITDA was largely in line with estimates, with key segments such as aluminium, oil and gas, and power faring better than its expectations, leading to an overall segmental EBITDA beat. On the earnings trajectory for the current and next fiscal, the firm expects various ongoing initiatives at Vedanta to aid growth. "Vedanta's capacity expansion journey in the aluminium business as well as vertical integration should bring cost advantages. LME prices have also bottomed out and should continue to move higher into FY26-27, likely aiding earnings growth." Echoing similar views on LME prices and its potential benefit, Citi Research cited that Vedanta's parent (Vedanta Resources) leverage is at comfortable levels. It listed potential upside in medium-term aluminium LME prices, lower cost, and the demerger as another positive for Vedanta, while adding that aluminium globally has a limited supply growth. Mumbai-based Nuvama Institutional Equities expects Vedanta to deliver quarter-on-quarter EBITDA growth in Q2. "Q2FY26 EBITDA is likely to increase 10 per cent-plus quarter-on-quarter on the back of higher prices and lower aluminium cost of production. Major aluminium projects are likely to be commissioned in Q2FY26. We reckon net debt/EBITDA ex-Hindustan Zinc shall fall to 1.7x by FY26-end, compared to 2.7x in FY25. Demerger of the business is likely to be concluded in Q4FY26," the firm said in its report. The brokerage expects Vedanta's all major projects except coal blocks to be likely commissioned in the current fiscal, providing volume growth and cost reduction visibility for the company. UK-based Investec stated in its post-earnings report that Vedanta is a key beneficiary of depreciation in the Indian Rupee. Other near-term positives listed by the firm include declining alumina prices and the company offering attractive yields. The firm has retained its buy recommendation on Vedanta. Research firms like Kotak Institutional Equities and IIFL have cited factors like cost efficiencies and deleveraging at both Vedanta Ltd and its parent Vedanta Resources as beneficial factors. Vedanta's adjusted profit after tax jumped 13 per cent year-on-year to Rs 5,000 crore. The company clocked its highest-ever first-quarter EBITDA of Rs 10,746 crore, which was up 5 per cent year-on-year.


The Hindu
14 minutes ago
- The Hindu
SIR in Bihar an 'invasive reconstruction of electoral roll:' Dipankar Bhattacharya
Describing the Special Intensive Revision (SIR) drive under way in Bihar as 'an invasive reconstruction of the electoral roll,' Dipankar Bhattacharya, general secretary of the Communist Party of India (Marxist-Leninist) Liberation, said States including Kerala should be on guard as it could be applied in other parts of the country as well. 'If they get away with it in Bihar, they will apply it everywhere,' he said, delivering the 24th memorial lecture in memory of the journalist N. Narendran on the topic 'Bihar: Trial run for Mass Disenfranchisement.' 'In fact, some people in Kerala and Tamil Nadu may still be believing that, well, this is something only happening in north India. If it is happening in north India, it is only a matter of time it happens here. No part of India is secure. Every State, every community, every political geography, every social equation, is vulnerable,' he said. The concept of citizenship as Indians have known it no longer remains valid as people will now be forced to prove their citizenship. The migrant workers of Bihar have emerged as one of the most vulnerable sections of electors in the SIR in Bihar, given the Election Commission of India's definition of 'ordinary resident.' This could have implications for Kerala as well, which has a large migrant population, he said. The SIR in Bihar, he said, was not just about rewriting the electoral roll, but it was about rewriting the electoral rules, he said. 'By rewriting the electoral rules, you are rewriting the entire grammar of elections in India,' he said. Mr. Dipankar Bhattacharya said that the INDIA Bloc was the need of the hour, observing that the BJP has grown at the expense of all other parties. 'If we cannot identify who the common enemy is, we will be doing so at our own peril,' he said. He underscored the need for a broad-based, sustained and multi-pronged resistance against what he described as the 'fascist offensive' of the BJP-RSS in the country. On the BJP's 'One Nation, One Election' proposal, Mr. Bhattacharya said it holds grave implications for the concepts of democracy and federalism. 'Every election has its own context. A Lok Sabha election has its own context, an Assembly election has its own context, a panchayat election will have its own context. If you bulldoze, flatten everything into one single narrative, and one single context for the whole elections, there will be nothing left of India's federalism and democracy as we have known it all these years,' he said, adding that the current challenges facing the Indian people is unlike any other in the post-Independence era.